Search results
15 sie 2024 · The imposed MFP for a 30-day equivalent supply of ELIQUIS, which is the price that Medicare will pay for ELIQUIS as of January 1, 2026, is $231.00.
By 2030, up to 80 drugs will have lower negotiated prices. One of the first ten drugs selected for negotiation is Eliquis, a drug used to treat blood clots, manufactured by Bristol Myers Squibb and Pfizer.
30 sty 2023 · USA TODAY. With pharmaceutical companies hiking prices on nearly 1,000 drugs in January, some consumers might experience sticker shock next time they pick up prescriptions. The price increases...
15 sie 2024 · Today, the U.S. Department of Health and Human Services released the “Maximum Fair Price” (MFP) for a 30-day supply of ELIQUIS® (apixaban), which was selected in the first round of government price setting as part of the Inflation Reduction Act (IRA).
15 sie 2024 · Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer: $231 negotiated price, down from $521 list price. Xarelto, a blood thinner from Johnson & Johnson: $197 negotiated price, down from...
6 lut 2024 · Medicare has started its first-ever negotiations with drugmakers over the cost of 10 expensive medications, including Eliquis and Stelara. The prices charged in other countries are not a factor...
Starting in 2024, the law expands the Extra Help program, which makes premiums and copays more affordable for people with limited resources with Medicare prescription drug coverage. And in 2025, the new $2,000 maximum out-of-pocket cap will provide additional help to those enrolled in a Medicare Part D plan.
